Chemoinformaics analysis of (1S,4R,5R)-Thujane-4-ol acetate
| Molecular Weight | 196.29 | nRot | 2 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 23 |
| Exact Molecular Weight | 196.146 | nRing | 2 |
| Solubility: LogS | -6.519 | nHRing | 0 |
| Solubility: LogP | 7.595 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 34.9799 |
| nHD | 0 | BPOL | 22.6681 |
| QED | 0.397 |
| Synth | 5.551 |
| Natural Product Likeliness | 3.137 |
| NR-PPAR-gamma | 0.073 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.012 |
| Pgp-sub | 0 |
| HIA | 0.009 |
| CACO-2 | -5.005 |
| MDCK | 0.00000853 |
| BBB | 0.422 |
| PPB | 1.003 |
| VDSS | 1.522 |
| FU | 0.0158767 |
| CYP1A2-inh | 0.022 |
| CYP1A2-sub | 0.502 |
| CYP2c19-inh | 0.066 |
| CYP2c19-sub | 0.963 |
| CYP2c9-inh | 0.09 |
| CYP2c9-sub | 0.415 |
| CYP2d6-inh | 0.076 |
| CYP2d6-sub | 0.874 |
| CYP3a4-inh | 0.367 |
| CYP3a4-sub | 0.647 |
| CL | 14.413 |
| T12 | 0.007 |
| hERG | 0.18 |
| Ames | 0.019 |
| ROA | 0.11 |
| SkinSen | 0.359 |
| Carcinogencity | 0.018 |
| EI | 0.07 |
| Respiratory | 0.862 |
| NR-Aromatase | 0.533 |
| Antiviral | Yes |
| Prediction | 0.62467 |